Acceptability and Feasibility of Medical Abortion in Singapore

• Status: Completed
• Trial end date: 2017-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

To test the hypothesis that a regimen of 200 mg oral mifepristone, with the option of home administration, followed by 800 μg buccal misoprostol 24 hours later for abortion through 70 days LMP will be feasible and acceptable in Singapore.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Treatments: Mifepristone; Misoprostol

Criteria

Inclusion Criteria:

• Have an intrauterine pregnancy consistent wit gestational age ≤ 70 days

• Be 21 years of age or over

• Be willing and able to sign consent forms

• Be eligible for abortion according to current hospital guidelines

• Be able to return to the clinic and able to contact study staff or emergency medical services if needed

• Be willing to provide an address, email and/or telephone number for purposes of follow-up

• Agree to comply with the study procedures and visit schedule

Exclusion Criteria:

• confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass

• chronic renal failure

• concurrent long-term corticosteroid therapy

• history of inherited porphyrias

• IUD in place (must be removed after mifepristone is administered).